Related Experiment Video
Updated: Mar 14, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
6.1K
Antithrombotic Approaches in Acute Coronary Syndromes: Optimizing Benefit vs Bleeding Risks
Mandeep Singh1, Deepak L Bhatt2, Gregg W Stone3
1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Mayo Clinic Proceedings
|October 8, 2016
Summary
Managing acute coronary syndrome (ACS) requires balancing antithrombotic therapies to reduce ischemia without increasing bleeding. This review guides healthcare providers in individualizing treatment for better patient outcomes.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Acute coronary syndrome (ACS) affects 620,000 individuals annually in the US, with 70% experiencing non-ST-elevation ACS.
- Cardiovascular disease remains a leading cause of death, necessitating improved ACS patient prognosis.
- While newer antithrombotic therapies reduce ischemic events, they increase bleeding risk, complicating treatment decisions.
Purpose of the Study:
- To synthesize current knowledge on antithrombotic therapy for acute coronary syndrome.
- To provide healthcare providers with evidence-based information for individualizing treatment decisions.
- To address the challenge of selecting antithrombotic combinations that minimize recurrent ischemia and bleeding.
Main Methods:
- Review of contemporary antithrombotic therapies for acute coronary syndrome.
- Synthesis of data on balancing ischemic versus bleeding risks.
- Analysis of therapeutic strategies for non-ST-elevation acute coronary syndrome.
Main Results:
- Newer antithrombotic agents offer benefits but increase bleeding complications.
- Individual patient risk for ischemia and hemorrhage must guide therapeutic choices.
- Optimal antithrombotic strategies require careful consideration of patient-specific factors.
Conclusions:
- Personalized antithrombotic therapy is crucial for managing acute coronary syndrome.
- Balancing antithrombotic efficacy and safety is key to improving patient prognosis.
- Healthcare providers need updated knowledge to navigate complex treatment decisions in ACS.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
376
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
376
01:27Coronary Artery Disease V: Interprofessional Care
359
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
359
01:26Angina IV: Management
374
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
374
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
01:29Venous Thrombosis III: Interprofessional Care
449
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
449